Tenaya Therapeutics, Inc. Short-term Investments
Tenaya Therapeutics, Inc. (TNYA) had Short-term Investments of $9.00 million as of 2025-06-30, per its 10-Q filed 2025-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:ShortTermInvestments · last filed 2026-03-11
- 2025-06-30: Short-term Investments $9.00M.
- 2025-03-31: Short-term Investments $34.39M.
- 2024-12-31: Short-term Investments $57.12M.
- 2024-09-30: Short-term Investments $71.24M.
| Period end | Short-term Investments |
|---|---|
| 2025-06-30 | $9.00M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $34.39M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $57.12M 10-K · filed 2026-03-11 |
| 2024-09-30 | $71.24M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $41.17M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $62.95M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $58.96M 10-K · filed 2025-03-10 |
| 2023-09-30 | $39.60M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $56.94M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $75.27M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $91.25M 10-K · filed 2024-03-18 |
| 2021-12-31 | $213.17M 10-K · filed 2023-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |